Our team is committed to deliver therapeutic solutions to patients with high needs
LNC Therapeutics is the 1st company to harness the therapeutic potential of Christensenella
Our leadership
Passionate about innovation
A former researcher at the Institut Pasteur, Georges was Vice-President of Business Development & Intellectual Property and a member of the management team at Celyad.
Beyond the state of the art
Sandrine joined LNC Therapeutics in 2017 as Chief Scientific Officer and is also Associate Professor in Integrative Metabolism in the department of Food and Nutritional Sciences at the University of Reading.
Putting people first
An experienced CFO, Fabrice decided to switch gears after gaining extensive experience as a financial auditor, getting involved in operations at a number of pharmaceutical SMEs, where he successfully headed up change management processes.
